1984Steinkopff eBooksRequires access

Intra-arterial ambulatory blood pressure monitoring in the assessment of antihypertensive drugs

R. I. Jones, B A Gould, R.S. Hornung, Stewart Mann, E. B. Raftery

Open publisher page 2 citations

Abstract

Direct measurement of blood pressure in ambulatory patients was performed with the intra-arterial “Oxford System” to assess the effectiveness of differing antihypertensive agents. The betablocker, metoprolol (200 mg daily), decreased daytimed blood pressure from 174/95 mmHg to 158/85 mmHg; the combination of metoprolol and chlorthalidone (25 mg daily) further decreased the mean daytime pressure to 143/78 mmHg (p < 0.001 systolic, p < 0.005 diastolic). The calcium channel blockers, nifedipine (20–40 mg twice daily) and verapamil (120–160 mg three times daily), each significantly decreased the nifedipine, but decreased significantly with verapamil. The angiotensin converting enzyme inhibitor, enalopril (20–40 mg daily), significantly decreased blood pressure for 18 of 24 hours, the antihypertensive effect being most pronounced during the daytime period. These experiences indicate that the technique of direct ambulatory blood pressure monitoring is of value in studying both the efficacy and the duration of antihypertensive treatment.mean hourly blood pressure during most of the day (23 of 24 hours with nifedipine, 15 of 24 hours of verapamil). Heart rate did not change with nifedipine, but decreased significantly with verapamil. The angiotensin converting enzyme inhibitor, enalopril (20–40 mg daily), significantly decreased blood pressure for 18 of 24 hours, the antihypertensive effect being most pronounced during the daytime period. These experiences indicate that the technique of direct ambulatory blood pressure monitoring is of value in studying both the efficacy and the duration of antihypertensive treatment.

About this research paper

What this paper is about

Direct measurement of blood pressure in ambulatory patients was performed with the intra-arterial “Oxford System” to assess the effectiveness of differing antihypertensive agents. The betablocker, metoprolol (200 mg daily), decreased daytimed blood pressure from 174/95 mmHg to 158/85 mmHg; the combination of metoprolol and chlorthalidone (25 mg daily) further decreased the mean daytime pressure to 143/78 mmHg (p < 0.001 systolic, p < 0.005 diastolic). The calcium channel blockers, nifedipine (20–40 mg twice daily) and verapamil (120–160 mg three times daily), each significantly decreased the nifedipine, but decreased significantly with verapamil. The angiotensin converting enzyme inhibitor, enalopril (20–40 mg daily), significantly decreased blood pressure for 18 of 24 hours, the antihypertensive effect being most pronounced during the daytime period. These experiences indicate that the technique of direct ambulatory blood pressure monitoring is of value in studying both the efficacy and the duration of antihypertensive treatment.mean hourly blood pressure during most of the day (23 of 24 hours with nifedipine, 15 of 24 hours of verapamil). Heart rate did not change with nifedipine, but decreased significantly with verapamil. The angiotensin converting enzyme inhibitor, enalopril (20–40 mg daily), significantly decreased blood pressure for 18 of 24 hours, the antihypertensive effect being most pronounced during the daytime period. These experiences indicate that the technique of direct ambulatory blood pressure monitoring is of value in studying both the efficacy and the duration of antihypertensive treatment.

Why it matters

OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Direct measurement of blood pressure in ambulatory patients was performed with the intra-arterial “Oxford System” to assess the effectiveness of differing antihypertensive agents. The betablocker, metoprolol (200 mg daily), decreased daytimed blood pressure from 174/95 mmHg to 158/85 mmHg; the combination of metoprolol and chlorthalidone (25 mg daily) further decreased the mean daytime pressure to 143/78 mmHg (p < 0.001 systolic, p < 0.005 diastolic). The calcium channel blockers, nifedipine (20–40 mg twice daily) and verapamil (120–160 mg three times daily), each significantly decreased the nifedipine, but decreased significantly with verapamil. The angiotensin converting enzyme inhibitor, enalopril (20–40 mg daily), significantly decreased blood pressure for 18 of 24 hours, the antihypertensive effect being most pronounced during the daytime period. These experiences indicate that the technique of direct ambulatory blood pressure monitoring is of value in studying both the efficacy and the duration of antihypertensive treatment.mean hourly blood pressure during most of the day (23 of 24 hours with nifedipine, 15 of 24 hours of verapamil). Heart rate did not change with nifedipine, but decreased significantly with verapamil. The angiotensin converting enzyme inhibitor, enalopril (20–40 mg daily), significantly decreased blood pressure for 18 of 24 hours, the antihypertensive effect being most pronounced during the daytime period. These experiences indicate that the technique of direct ambulatory blood pressure monitoring is of value in studying both the efficacy and the duration of antihypertensive treatment.

Key concepts: Nifedipine, Blood pressure, Verapamil, Medicine, Ambulatory blood pressure, Metoprolol, Chlorthalidone, Ambulatory

Related papers

Back to paper searchBrowse research topicsOriginal source
Intra-arterial ambulatory blood pressure monitoring in the assessment of antihypertensive drugs — Research Paper | ScholarLens